Canada's alliance for excellence in clinical research

From left to right: Thérèse Gagnon-Kugler (Q-CROC), Cynthia Lévesque (CIUSSS de l’Est-de-l’Île-de-Montréal), Hugo Garneau (CHU de Québec – Université Laval), Stéphanie Ibrahim (CIUSSS du Nord-de-l’Île-de-Montréal), Tasnim Daginawala (CIUSSS du Centre-Ouest-de-l’Île-de-Montréal), Philippe Cornellier (Q-CROC), Claire Gagnon (CISSS du Bas-Saint-Laurent), Martin Gaudreau (Q-CROC), Mélanie LeBlanc (Q-CROC), Marie-Pierre Desrosiers (CISSS de l’Outaouais), Anne Brochu (CIUSSS de l’Estrie – […]

February 10, 2017

En savoir plus

Sainte-Justine joins the Quebec clinical research network in oncology

  Q-CROC is pleased to welcome the CHU Sainte-Justine as the 11th member-institution of its clinical research network in oncology.   CHU Sainte-Justine has positioned itself Canada’s largest mother-child hospital center and one of the ten largest pediatric centers in the world. CHU Sainte-Justine hosts a cancer center, in charge of the pediatric bone marrow and […]

January 22, 2017

En savoir plus

Scientists have identify a DNA signature linked to prostate cancer severity

The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the a comprehensive genetic analysis of prostate cancer tumors in the journal Nature. This project was financed by Prostate Cancer Canada with the help of donations received through the Movember campaign.   Watch the video published by Prostate Cancer Canada via its YouTube channel.    […]

January 11, 2017

En savoir plus

50th liaison coordinators meeting

From left to right: Solange Tremblay (CISSS de Laval), Anne Brochu (CIUSSS de l’Estrie – CHUS), Claire Gagnon (CISSS du Bas-Saint-Laurent), Marie Saint-Jacques (CHU Sainte-Justine), Cynthia Lévesque (CIUSSS de l’Est-de-l’Île-de-Montréal), Martin Gaudreau (Q‑CROC), Tasnim Daginawala (CIUSSS du Centre-Ouest-de-l’Île-de-Montréal), Hugo Garneau (CHU de Québec – Université Laval), Anrrieth Paredes (CHUM). Absents de la photo, mais présents […]

December 31, 2016

En savoir plus

Portfolio of clinical trials in oncology in Quebec and databases

  Through its role as network coordinator and clinical research development organization, Q-CROC has been able to collect a wide range of relevant evidence pertaining to clinical research in oncology in Quebec. This real world evidence constitutes a valuable observational tool capable of monitoring the vitality of this sector with the aim of better promoting it. Our […]

November 21, 2016

En savoir plus

Clinical Development Success Rates

    The Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus on the advantages of using biomarkers in clinical trials.     Some of the conclusions:  Clinical trial programs that used selection biomarkers saw an overall likelihood of approval (LOA) from Phase I of 25.9%, compared to […]

June 1, 2016

En savoir plus

In partnership with Q-CROC, Esperas will invest up to $7M in a clinical trial that aims to provide first access to promising new treatment for Quebec cancer patients

  MONTREAL, April 11, 2016 /CNW Telbec/ – Esperas Pharma Inc. (“Esperas”) today announced the initiation of a project to develop a new oral anticancer agent called ESP-01, in partnership with Quebec Clinical Research Organization in Cancer (Q-CROC). Esperas will develop ESP-01 in the province of Québec for the next three and a half years, […]

April 11, 2016

En savoir plus